VPS35 Human Pre-designed siRNA Set A
Based on 1 publication(s) in Google Scholar
VPS35 Human Pre-designed siRNA Set A contains three designed siRNAs for VPS35 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
For research use only. We do not sell to patients.
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications Citing Use of MedChemExpress (MCE) VPS35 Human Pre-designed siRNA Set A
More
Biological Activity
VPS35 Human Pre-designed siRNA Set A contains three designed siRNAs for VPS35 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Components
VPS35 siRNA-1: 5 nmol (HPLC)
VPS35 siRNA-2: 5 nmol (HPLC)
VPS35 siRNA-3: 5 nmol (HPLC)
siRNA Negative Control: 5 nmol (HPLC)
FAM-labeled siRNA Negative Control: 5 nmol (HPLC)
GAPDH siRNA Positive Control: 5 nmol (HPLC)
VPS35 - VPS35 retromer complex component Gene (Human)
MEM3; PARK17
Chemical Information
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications (1)
-
Journal Impact Factor
-
Most Recent
-
RSC Med Chem
Comprehensive multi-omics analysis and experimental validation indicate that VPS35 is a promising biomarker for prognosis, immunotherapy, and chemotherapy in LIHC. [Abstract]2026 Jan 12;17(2):1107-1134. PMID: 41531939
Purity & Documentation
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)